BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Capital Southwest
CSWC
$1.6B
| $1.91M | ﹤0.01% |
91,661
+4,059
| +5% | +$87.8K |
|
|
FOMX
3752
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.88M | ﹤0.01% |
564,004
-33,348
| -6% | -$106K |
|
3753
Ovid Therapeutics
OVID
$491M
| $1.87M | ﹤0.01% |
450,746
+315,948
| +234% | +$998K |
|
3754
Embotelladora Andina Series B
AKO.B
$4.95B
| $1.86M | ﹤0.01% |
106,297
| – | – |
|
3755
Microbot Medical
MBOT
$127M
| $1.86M | ﹤0.01% |
182,896
-96
| -0.1% | -$563 |
|
3756
Gyre Therapeutics
GYRE
$744M
| $1.85M | ﹤0.01% |
36,158
-44
| -0.1% | -$1.84K |
|
|
BKCC
3757
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.84M | ﹤0.01% |
369,995
+19,782
| +6% | +$97.2K |
|
3758
Babcock & Wilcox
BW
$1.39B
| $1.83M | ﹤0.01% |
502,290
+63,815
| +15% | +$249K |
|
|
BEDU
3759
DELISTED
Bright Scholar Education Holdings
BEDU
| $1.81M | ﹤0.01% |
51,133
+4,984
| +11% | +$185K |
|
|
SY
3760
So-Young International
SY
$219M
| $1.79M | ﹤0.01% |
146,792
-172,048
| -54% | -$1.9M |
|
3761
Gran Tierra Energy
GTE
$317M
| $1.76M | ﹤0.01% |
136,558
+2,976
| +2% | +$32.4K |
|
3762
INNOVATE Corp
VATE
$165M
| $1.76M | ﹤0.01% |
81,050
+6,800
| +9% | +$150K |
|
|
YGYI
3763
DELISTED
Youngevity International, Inc Common Stock
YGYI
| $1.76M | ﹤0.01% |
538,762
+10,919
| +2% | +$45.9K |
|
3764
Phunware
PHUN
$43.6M
| $1.75M | ﹤0.01% |
29,483
+10,358
| +54% | +$714K |
|
|
STCN
3765
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $1.75M | ﹤0.01% |
128,429
-43
| -0% | -$599 |
|
|
TUES
3766
DELISTED
Tuesday Morning Corp
TUES
| $1.75M | ﹤0.01% |
943,336
-597
| -0.1% | -$950 |
|
3767
Blue Owl Capital
OBDC
$5.74B
| $1.74M | ﹤0.01% |
97,294
+96,462
| +11,594% | +$1.69M |
|
3768
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
| $1.73M | ﹤0.01% |
23,578
-2,662
| -10% | -$186K |
|
|
CTRC
3769
DELISTED
Centric Brands Inc. Common Stock
CTRC
| $1.71M | ﹤0.01% |
789,145
-1,877
| -0.2% | -$4.69K |
|
3770
Cumberland Pharmaceuticals
CPIX
$117M
| $1.71M | ﹤0.01% |
331,559
-597
| -0.2% | -$3.15K |
|
3771
Corvus Pharmaceuticals
CRVS
$1.17B
| $1.71M | ﹤0.01% |
313,837
-20,259
| -6% | -$70.9K |
|
|
XONE
3772
DELISTED
The ExOne Company
XONE
| $1.7M | ﹤0.01% |
228,174
-177
| -0.1% | -$1.26K |
|
|
IO
3773
DELISTED
ION Geophysical Corporation
IO
| $1.7M | ﹤0.01% |
195,932
+212
| +0.1% | +$1.83K |
|
3774
Nuveen Global High Income Fund
JGH
$356M
| $1.69M | ﹤0.01% |
103,358
| – | – |
|
|
RTW
3775
DELISTED
RTW Retailwinds, Inc.
RTW
| $1.68M | ﹤0.01% |
2,095,646
+13,727
| +0.7% | +$17.3K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.